Scope of the Study
Viral Diagnostic Test Kits are effectively used in diagnostic platforms to provide the timely detection and control of infectious diseases caused by viral agents. The current outbreak of coronavirus pandemics has been exerting a significant economic cost burden on health care systems around the world. To have accurate and rapid diagnostic test results for viral diseases the use of viral diagnostic test kits has increased. For instance, as of May 2020, due to the outbreak of COVID-19, there were 5,633,413 coronavirus infected patients of which 349,073 people have died of the disease globally. The demand for instant and accurate diagnostic results has driven the growth of the global viral diagnostic test kits market.
The market study is being classified by Type (Influenza Test Kits, Hepatitis Test Kits, Human Immunodeficiency Virus Test Kits, Respiratory Syncytial Virus Test Kits and Other) and major geographies with country level break-up.
Abbott Laboratories (United States), Autobio Diagnostics Co (China), Certest Biotec S.L. (Spain), CorisBioconcept SPRF (Belgium), F. Hoffman La Roche, Ltd. (Switzerland), VIDIA s.r.o (Czechia), Hologic Inc. (United States), bioMérieux SA (France), Quidel Corporation (United States), Thermo Fisher Scientific (United States), Becton, Dickinson and Company (United States), Luminex Corporation (United States), Nectar Lifesciences (India), Cortez Diagnostics (United States) and Bundi International Diagnostics (Nigeria) are some of the key players profiled in the study.
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Viral Diagnostic Test Kits market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Viral Diagnostic Test Kits market by Type, Application and Region.
On the basis of geography, the market of Viral Diagnostic Test Kits has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Rising Incidence of Viral Infections such as HIV, Hepatitis, and Respiratory Syncytial Virus
- Rapid Spread of Virus in Large Population Countries such as China and India
- Inclination Towards Self-Diagnosis of Viral Diseases
- Continuous Variation in Viral Genome & Varied Environmental Condition
- Development of Precise Rapid Screening Tests With Improved Detection Time
- Outbreak of New Viral Infection such as Covid-19, Ebola, and Swine Influenza
- Increasing Number of Startups in Viral Diagnostic Test Kits Manufacturing
- Lack Of Expertise and Low Awareness About Diagnostic Tests
In May 2020, Biolidics launched rapid test kit for COVID-19 named ‘2019-nCoV IgG/IgM’. The rapid test kit identifies antibodies to SARS-CoV-2-the virus that causes COVID-19 at an accuracy of more than 95 per cent in 10 minutes. This is kit is for use by clinical laboratories or healthcare workers for point-of-care testing.
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Viral Diagnostic Test Kits Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End Use Industry
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase